🔍
High-throughput in vivo screening platform for chemical and genetic modulators of Apoliprotein-B
Case ID:
C14191
Report of Invention:
5/6/2016
Web Published:
3/17/2017
Unmet Need:
Rapid and sensitive screening platform to develop diagnostic tests for metabolic diseases.
Technology Overview:
Elevated serum Apolipoprotein-B (ApoB) may represent a unifying risk factor underlying many of the world’s most prevalent metabolic diseases. ApoB levels independently predict incidence of diabetes, metabolic syndrome, and cardiovascular disease even after adjusting for confounding variables Elevated serum Apolipoprotein-B (ApoB) may represent a unifying risk factor underlying many of the world’s most prevalent metabolic diseases. ApoB levels independently predict incidence of diabetes, metabolic syndrome, and cardiovascular disease even after adjusting for confounding variables. The technology is an
in-vivo
high-throughput screening assay for modulators of ApoB in the larval zebrafish. For this purpose we have engineered the first ever transgenic zebrafish carrying a luciferase reporter fused to ApoB, which enables rapid and sensitive reporter quantification in 96-well plate format.
Results indicaqte that the assay is not disruptive to zebrafish metabolism, is responsive to physiological and pharmaceutical treatments, is statistically robust, and compatible with existing automated high-throughput screening platforms.
Stage of Development:
This technology is currently being developed by research within Johns Hopkins University.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
HIGH-THROUGHPUT IN VIVO SCREENING PLATFORM FOR MODULATORS OF APOLIPOPROTEIN-B
ORD: Ordinary Utility
United States
15/611,780
10,551,393
6/1/2017
2/4/2020
7/26/2038
Granted
Direct Link:
https://jhu.technologypublisher.com/technology/24900
Inventors:
Category(s):
Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Research Tools, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Metabolic Diseases,
Get custom alerts for techs in these categories/from these inventors:
Subscribe for JHTV Updates
For Information, Contact:
Jeanine Pennington
jpennin5@jhmi.edu
410-614-0300
Save This Technology:
Bookmark this page
Download as PDF
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum